44 of the patients in the AAA approach of Hansen et al. experienced arterial hypertension [33], but this refers only to the test phase. During the pinning, craniotomy and tumour resection there were only 5 patients with 10?0 increase in blood pressure. Additional analyses. The analysis of the composite outcome, including AC failure, intraoperative seizure and mortality was based on forty-one studies (S1 Fig) [10,17?6,28?0,32,34?41,43,46?2]. Of note, intraoperative seizure events, which concurrently led to an AC failure, were counted only once for this composite outcome. The total proportion was estimated to be 8 [95 CI: 6?1], with 8 [95 CI: 6?2] in the MAC group and 8 [95 CI: 5?2] in the SAS group. Logistic meta-regression did not show a difference of the event rate depending on the technique (MAC/ SAS). The OR was 0.9 [95 CI: 0.47?.76] and the residual heterogeneity I2 = 80 .PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,32 /Anaesthesia Management for Awake CraniotomyFig 4. Forrest plot of intraoperative seizures. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of Mitochondrial division inhibitor 1 chemical information outcome proportion (based on the meta-analysis) disregarding grouping by technique. Of note, Souter et al. [60] have used both anaesthesia techniques. doi:10.1371/journal.pone.0156448.gSensitivity analysis, by including only prospectively conducted trials, was performed to look at the robustness of our findings in the main summary measure U0126-EtOH chemical information analyses of the four outcomes (AC failure, conversion to GA, intraoperative seizure and new neurological dysfunction) andPLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,33 /Anaesthesia Management for Awake CraniotomyFig 5. Forrest plot of new neurological dysfunction. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Neurol. dysf., neurological dysfunction. doi:10.1371/journal.pone.0156448.gthe additional analysis of the composite outcome. Sensitivity analysis referred to eighteen trials [10,17,18,21,22,25,26,28,30,32,35,36,38,47,52,55,56,61], after exclusion of one duplicate study [27]. Of note, it was not possible to predict an estimate for the outcome new neurological dysfunction in the SAS group, because only one prospective SAS study provided data for this outcome [38]. The proportions of outcomes were slightly lower in prospective studies compared to results from the main analysis, which is shown in S2 Fig. The logistic meta-regression models using the independent variables anaesthesia technique (MAC/ SAS) and prospective studies (yes/ no) showed only very small and statistically not significant differences.PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,34 /Anaesthesia Management for Awake CraniotomyDiscussionOur systematic review has pointed out forty-seven studies addressing three main topics: SAS-, MAC- and AAA-technique of anaesthesia management for AC since 2007. We identified only two small RCTs [32,56] and one pseudo-RCT [36]. These were as well as the remaining observational studies of moderate to low methodological quality. In summary all three anaesthetic approaches were feasible and safe. But our results have to be seen within their limits. Nine of the identified forty-seven studies reported partially duplicate patient data, first the studies of Ouyang et al. [45,46], second the s.44 of the patients in the AAA approach of Hansen et al. experienced arterial hypertension [33], but this refers only to the test phase. During the pinning, craniotomy and tumour resection there were only 5 patients with 10?0 increase in blood pressure. Additional analyses. The analysis of the composite outcome, including AC failure, intraoperative seizure and mortality was based on forty-one studies (S1 Fig) [10,17?6,28?0,32,34?41,43,46?2]. Of note, intraoperative seizure events, which concurrently led to an AC failure, were counted only once for this composite outcome. The total proportion was estimated to be 8 [95 CI: 6?1], with 8 [95 CI: 6?2] in the MAC group and 8 [95 CI: 5?2] in the SAS group. Logistic meta-regression did not show a difference of the event rate depending on the technique (MAC/ SAS). The OR was 0.9 [95 CI: 0.47?.76] and the residual heterogeneity I2 = 80 .PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,32 /Anaesthesia Management for Awake CraniotomyFig 4. Forrest plot of intraoperative seizures. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Of note, Souter et al. [60] have used both anaesthesia techniques. doi:10.1371/journal.pone.0156448.gSensitivity analysis, by including only prospectively conducted trials, was performed to look at the robustness of our findings in the main summary measure analyses of the four outcomes (AC failure, conversion to GA, intraoperative seizure and new neurological dysfunction) andPLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,33 /Anaesthesia Management for Awake CraniotomyFig 5. Forrest plot of new neurological dysfunction. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Neurol. dysf., neurological dysfunction. doi:10.1371/journal.pone.0156448.gthe additional analysis of the composite outcome. Sensitivity analysis referred to eighteen trials [10,17,18,21,22,25,26,28,30,32,35,36,38,47,52,55,56,61], after exclusion of one duplicate study [27]. Of note, it was not possible to predict an estimate for the outcome new neurological dysfunction in the SAS group, because only one prospective SAS study provided data for this outcome [38]. The proportions of outcomes were slightly lower in prospective studies compared to results from the main analysis, which is shown in S2 Fig. The logistic meta-regression models using the independent variables anaesthesia technique (MAC/ SAS) and prospective studies (yes/ no) showed only very small and statistically not significant differences.PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,34 /Anaesthesia Management for Awake CraniotomyDiscussionOur systematic review has pointed out forty-seven studies addressing three main topics: SAS-, MAC- and AAA-technique of anaesthesia management for AC since 2007. We identified only two small RCTs [32,56] and one pseudo-RCT [36]. These were as well as the remaining observational studies of moderate to low methodological quality. In summary all three anaesthetic approaches were feasible and safe. But our results have to be seen within their limits. Nine of the identified forty-seven studies reported partially duplicate patient data, first the studies of Ouyang et al. [45,46], second the s.
Related Posts
Reported Not reported 20668451 18948947 17344846 21720365 19718025 19718025 19718025 19718025 19718025 21499247 21097718 stomach skin skin skin melanoma melanoma melanoma carcinoma
Reported Not reported 20668451 18948947 17344846 21720365 19718025 19718025 19718025 19718025 19718025 21499247 21097718 stomach skin skin skin melanoma melanoma melanoma carcinoma skin melanoma skin melanoma skin melanoma ovary carcinoma ovary carcinoma TyrKc Ephrin_lbd TyrKc FN3 TyrKc Ephrin_lbd TyrKc Ephrin_lbd TyrKc lung carcinoma lung carcinoma TyrKc Between FN3 and TyrKc domains lung carcinoma Ephrin binding […]
SDS-PAGE on a 15 gel. The gel was dried and analyzed bySDS-PAGE on a
SDS-PAGE on a 15 gel. The gel was dried and analyzed bySDS-PAGE on a 15 gel. The gel was dried and analyzed by phosphorimaging.Results Endogenous Expression of Arylsulfatase K in Human Tissues– To confirm endogenous expression of human ARSK, we first analyzed its mRNA ranges. We looked for tissue-specific expression by RT-PCR of normalized cDNA […]
cis-4-(Boc-amino)cyclohexylamine, 97%
Product Name : cis-4-(Boc-amino)cyclohexylamine, 97%Synonym: IUPAC Name : CAS NO.:Molecular Weight : Molecular formula: Smiles: Description: cis-4-(Boc-amino)cyclohexylamine can be used in agrochemical, pharmaceutical and dyestuff field.Ceftriaxone Tetrahydroberberine PMID:25558565 MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced […]